Multicenter, randomized, double-blind, phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus standard pemetrexed therapy compared to placebo plus standard pemetrexed therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy
Grant Data
Project Title
Multicenter, randomized, double-blind, phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus standard pemetrexed therapy compared to placebo plus standard pemetrexed therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy
Principal Investigator
Dr Ho, James Chung Man
(Principal Investigator (PI))
Co-Investigator(s)
Dr Wang Julie Kwan Ling
(Co-Investigator)
Dr Lam Jamie Chung Mei
(Co-Investigator)
Dr Wong Matthew King Yan
(Co-Investigator)
Dr Lam David Chi Leung
(Co-Investigator)
Duration
45
Start Date
2009-04-01
Amount
328733
Conference Title
Multicenter, randomized, double-blind, phase III trial to investigate the efficacy and safety of oral BIBF 1120 plus standard pemetrexed therapy compared to placebo plus standard pemetrexed therapy in patients with stage IIIB/IV or recurrent non small cell lung cancer after failure of first line chemotherapy
Presentation Title
Keywords
Stage IIIB/V or recurrent NSCLC
Discipline
Respiration,Cancer
HKU Project Code
N/A
Grant Type
Pharmaceutical Industry - General Award
Funding Year
2008
Status
On-going